PHOSPHATE INORGANIC / PHOSPHORUS

Primary DI

06975225461193

Basic UDI-DI Code

B-06975225461193

Reference

DTSH080406

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Da Te Bioengineering Technology Co., LTD.

This kit is intended for in vitro quantitative detection of inorganic phosphorus (IP) in human serum. 88% of the phosphorus contained in the body is localized in bone in the form of calcium phosphate as the apatite Ca2+[Ca3(PO4)2 ]32-.The ratio of phosphate to calcium in the blood is approximately 6:10. An increase in the level of phosphorus causes a decrease in the calcium level. The mechanism is influenced by interactions between parathormone and vitamin D. Hypoparathyroidism, vitamin D intoxication and renal failure with decreased glomerular phosphate filtration give rise to hyperphosphatemia. Hypophosphatemia occurs in rickets, hyperparathyroidism and Fanconi's syndrome.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).